{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:57:25Z","timestamp":1793804245063,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008804","name":"Ministry of Science and Technology, Government of the People\u2019s Republic of Bangladesh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37178","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T14:40:52Z","timestamp":1725028852000},"page":"e37178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Multi-modal neuroprotection of Argemone mexicana L. against Alzheimer\u2019s disease: In vitro and in silico study"],"prefix":"10.1016","volume":"10","author":[{"given":"Md. Enamul Kabir","family":"Talukder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahina","family":"Akhter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foysal","family":"Ahammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmim","family":"Aktar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Saidul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysha Akter","family":"Laboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirola","family":"Afroze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mala","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Jashim","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3776-9855","authenticated-orcid":false,"given":"Md. Mashiar","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e37178_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-03142-w","article-title":"Diplazium esculentum (Retz.) Sw. reduces BACE-1 activities and amyloid peptides accumulation in Drosophila models of Alzheimer's disease","volume":"11","author":"Kunkeaw","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e37178_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-018-0107-y","article-title":"Alzheimer's disease hypothesis and related therapies","volume":"7","author":"Du","year":"2018","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.heliyon.2024.e37178_bib3","first-page":"101","article-title":"A network pharmacology-based study on key pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer's disease","volume":"149","author":"yue Xiao","year":"2021","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.heliyon.2024.e37178_bib4","first-page":"71","article-title":"In vitro anti-cholinesterase and antioxidant activity of extracts of moringa oleifera plants from rivers state, Niger delta, Nigeria","volume":"5","author":"Nwidu","year":"2018","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.heliyon.2024.e37178_bib5","first-page":"208","article-title":"Drugs for Alzheimer's disease: are they effective?","volume":"35","author":"Casey","year":"2010","journal-title":"P T"},{"key":"10.1016\/j.heliyon.2024.e37178_bib6","doi-asserted-by":"crossref","first-page":"13170","DOI":"10.1073\/pnas.93.23.13170","article-title":"Evidence that the 42- and 40-amino acid forms of amyloid \u03b2 protein are generated from the \u03b2-amyloid precursor protein by different protease activities","volume":"93","author":"Citron","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heliyon.2024.e37178_bib7","article-title":"Evaluating the role of N-Acetyl-L-Tryptophan in the A\u03b2 1-42-induced neuroinflammation and cognitive decline in Alzheimer's disease","author":"Satarker","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.heliyon.2024.e37178_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmolb.2022.1002710","article-title":"Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications","volume":"9","author":"Mengstie","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.heliyon.2024.e37178_bib9","unstructured":"V.N. Bukke, M. Archana, R. Villani, A.D. Romano, A. Wawrzyniak, K. Balawender, S. Orkisz, S. Beggiato, G. Serviddio, T. Cassano, The Dual Role of Glutamatergic Neurotransmission in Alzheimer \u2019 S Disease : from Pathophysiology to Pharmacotherapy, (n.d.) 1\u201328."},{"key":"10.1016\/j.heliyon.2024.e37178_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2019.00446","article-title":"Exploring the pathogenesis of Alzheimer disease in basal forebrain cholinergic neurons:Converging insights from alternative hypotheses","volume":"13","author":"Chen","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e37178_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-2-12","article-title":"Tau phosphorylation by GSK-3\u03b2 promotes tangle-like filament morphology","volume":"2","author":"Rankin","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.heliyon.2024.e37178_bib12","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1523\/JNEUROSCI.15-05-03318.1995","article-title":"Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation","volume":"15","author":"Reynolds","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e37178_bib13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e37178_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.931473","article-title":"Pathophysiology of RAGE in inflammatory diseases","volume":"13","author":"Dong","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e37178_bib15","article-title":"Aducanumab therapy to treat Alzheimer's disease: a narrative review","volume":"2022","author":"Beshir","year":"2022","journal-title":"Int. J. Alzheimer's Dis."},{"key":"10.1016\/j.heliyon.2024.e37178_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40263-019-00613-7","article-title":"A close look at BACE1 inhibitors for Alzheimer's disease treatment","volume":"33","author":"Das","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.heliyon.2024.e37178_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer's disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.heliyon.2024.e37178_bib18","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.3233\/JAD-179921","article-title":"Multifactorial hypothesis and multi-targets for Alzheimer's disease","volume":"64","author":"Gong","year":"2018","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.heliyon.2024.e37178_bib19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1590\/S0102-695X2013005000021","article-title":"Argemone mexicana: chemical and pharmacological aspects","volume":"23","author":"Brahmachari","year":"2013","journal-title":"Rev. Bras. Farmacogn."},{"key":"10.1016\/j.heliyon.2024.e37178_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28114428","article-title":"Analysis of biochemical and antimicrobial properties of bioactive molecules of Argemone mexicana","volume":"28","author":"Jaiswal","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e37178_bib21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3923\/ajbs.2020.264.269","article-title":"Comparative phytochemical characterization of the Argemone mexicana and Thevetia peruviana leaves extracts","volume":"13","author":"Singh","year":"2019","journal-title":"Asian J. Bio. Sci."},{"key":"10.1016\/j.heliyon.2024.e37178_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.31080\/ASMI.2020.03.0524","article-title":"A comparative study of antimicrobial and pharmacological properties of Argemone mexicana, Solanum xanthocarpum and Thevetia peruviana","volume":"3","author":"Jaiswal","year":"2020","journal-title":"Acta Sci Microbiol"},{"key":"10.1016\/j.heliyon.2024.e37178_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7324\/JAPS.2020.102017","article-title":"Mikania cordata leaves extract promotes activity against pathogenic bacteria and anticancer activity in EAC cell-bearing swiss albino mice","volume":"10","author":"Rahman","year":"2020","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2024.e37178_bib24","doi-asserted-by":"crossref","first-page":"40120","DOI":"10.1039\/D1RA06842C","article-title":"GC-MS analysis of phytoconstituents fromRuellia prostrataandSenna toraand identification of potential anti-viral activity against SARS-CoV-2","volume":"11","author":"Alam","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.heliyon.2024.e37178_bib25","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e37178_bib26","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e37178_bib27","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1021\/jm4002154","article-title":"Spirocyclic \u03b2-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid \u03b2 in a higher species","volume":"56","author":"Hunt","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e37178_bib28","doi-asserted-by":"crossref","first-page":"45937","DOI":"10.1074\/jbc.M306268200","article-title":"Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-a014418","volume":"278","author":"Bhat","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e37178_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.heliyon.2024.e37178_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscs.2021.101401","article-title":"Ruellia prostrata Poir. activity evaluated by phytoconstituents, antioxidant, anti-inflammatory, antibacterial activity, and in silico molecular functions","volume":"26","author":"Akhter","year":"2022","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.heliyon.2024.e37178_bib31","article-title":"Evaluation of Senna tora (L.) Roxb. leaves as source of bioactive molecules with antioxidant, anti-inflammatory and antibacterial potential","volume":"9","author":"Rahman","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e37178_bib32","first-page":"1","article-title":"Assessment of secondary metabolites, in-vitro antioxidant and anti-inflammatory activity of root of Argemone mexicana L","author":"Rakesh","year":"2023","journal-title":"ES Food Agrofor"},{"key":"10.1016\/j.heliyon.2024.e37178_bib33","first-page":"476","article-title":"Anxiolytic-like effect of ethanolic extract of Argemone mexicana and its alkaloids in Wistar rats","volume":"6","author":"Arcos-Mart\u00ednez","year":"2016","journal-title":"Avicenna J. Phytomedicine"},{"key":"10.1016\/j.heliyon.2024.e37178_bib34","first-page":"8011","volume":"vol. 12","author":"Mahendra","year":"2023"},{"key":"10.1016\/j.heliyon.2024.e37178_bib35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1359-6446(97)01163-X","article-title":"Virtual screening\u2014an overview","volume":"3","author":"Walters","year":"1998","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.heliyon.2024.e37178_bib36","article-title":"Navigating the GSK-3\u03b2 inhibitors as versatile multi-target drug ligands in Alzheimer's disease intervention\u2013A comprehensive review","author":"Joshi","year":"2024","journal-title":"Results Chem"},{"key":"10.1016\/j.heliyon.2024.e37178_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-05621-0","article-title":"Bioinformatics approaches identified dasatinib and bortezomib inhibit the activity of MCM7 protein as a potential treatment against human cancer","volume":"12","author":"Samad","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e37178_bib38","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.2147\/NDT.S114846","article-title":"Role of berberine in Alzheimer's disease","volume":"12","author":"Cai","year":"2016","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.heliyon.2024.e37178_bib39","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neuropharm.2017.08.013","article-title":"Berberine modulates amyloid-\u03b2 peptide generation by activating AMP-activated protein kinase","volume":"125","author":"Zhang","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.heliyon.2024.e37178_bib40","first-page":"1","article-title":"Protoberberine alkaloids, alkaloids","volume":"62","author":"Leitao da-Cunha","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.heliyon.2024.e37178_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.987800","article-title":"Acute, chronic, and genotoxic studies on the protopine total alkaloids of the Macleaya cordata (willd.) R. Br. in rodents","volume":"13","author":"Dong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e37178_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02105-5","article-title":"Protopine triggers apoptosis via the intrinsic pathway and regulation of ROS\/PI3K\/Akt signalling pathway in liver carcinoma","volume":"21","author":"Nie","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.heliyon.2024.e37178_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1742-7843.2007.00075.x","article-title":"Protective effect of protopine on the focal cerebral ischaemic injury in rats","volume":"101","author":"Xiao","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e37178_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106126","article-title":"Natural isoquinoline alkaloids: pharmacological features and multi-target potential for complex diseases","volume":"177","author":"Plazas","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e37178_bib45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/scipharm84030547","article-title":"In vivo anticonvulsant activity of extracts and protopine from the Fumaria schleicheri herb","volume":"84","author":"Prokopenko","year":"2016","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.heliyon.2024.e37178_bib46","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.neuropharm.2006.01.003","article-title":"Protopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice models","volume":"50","author":"Xu","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.heliyon.2024.e37178_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/BTAT.S33554","article-title":"Botanics: a potential source of new therapies for Alzheimer's disease?","author":"Devi","year":"2014","journal-title":"Botanics Targets Ther."},{"key":"10.1016\/j.heliyon.2024.e37178_bib48","first-page":"61","article-title":"Chronic pain treatment strategies in Parkinson's disease, Neurol","volume":"12","author":"Edinoff","year":"2020","journal-title":"Int."},{"key":"10.1016\/j.heliyon.2024.e37178_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/1049732315613764","article-title":"\u201ccodeine is my helper\u201d: misuse of and dependence on codeine-containing medicines in South Africa","volume":"27","author":"Van Hout","year":"2017","journal-title":"Qual. Health Res."},{"key":"10.1016\/j.heliyon.2024.e37178_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169328","article-title":"Antioxidant therapeutic strategies in neurodegenerative diseases","volume":"23","author":"Mor\u00e9n","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024132094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024132094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:16:59Z","timestamp":1790543819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024132094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":50,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024132094"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37178","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-modal neuroprotection of Argemone mexicana L. against Alzheimer\u2019s disease: In vitro and in silico study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37178"}}